Bicuculline methiodide in the blood-brain barrier-epileptogen model of epilepsy.
Focal epilepsy can be produced by a blood-brain barrier (BBB)-excluded systemic convulsant (penicillin, folic acid, etc.) in the presence of a focal BBB lesion. Bicuculline methiodide, a gamma-aminobutyric acid blocking epileptogen, crosses the normal BBB of rats poorly and produces no consistent abnormality behaviorally or on EEG at 36 mg/kg. When the BBB is opened in 0.25 ml of cortex by 6,000 rad of alpha particles, by a pin trauma lesion, or by a heat lesion, the rats are normal clinically and on EEG. When these lesioned rats are challenged with bicuculline methiodide, 36 mg/kg, an intense, highly localized epileptiform discharge results that begins approximately 20 min after injection and lasts 30-90 min. The plausibility and experimental utility of the BBB-epileptogen model of epilepsy are enhanced by these observations.
D000818:Animals; D001640:Bicuculline / Q000031:analogs & derivatives* / Q000502:physiology; D001812:Blood-Brain Barrier; D004827:Epilepsy / Q000139:chemically induced* / Q000209:etiology / Q000503:physiopathology; D006358:Hot Temperature; D008954:Models, Biological; D011827:Radiation
C017069:bicuculline methiodide; D001640:Bicuculline